Andrea M. Maxwell

Thesis Research

Identification of risk factors for substance use disorders and response to treatment.

Publications (pubmed)

Steele VR, Maxwell AM. Treating cocaine and opioid use disorder with transcranial magnetic stimulation: A path forward. Pharmacol Biochem Behav. 2021 Oct;209:173240. Review.

Jennings L, Branson CF, Maxwell AM, Winkelman TNA, Shlafer RJ. Physicians' perspectives on continuity of care for patients involved in the criminal justice system: A qualitative study. PLoS One. 2021 Jul 14;16(7):e0254578. PMCID: PMC8279398

Maxwell AM, Rao RB. Perinatal iron deficiency as an early risk factor for schizophrenia. Nutr Neurosci. 2021 Jun 24:1-10. Online ahead of print.

Gard AM, Maxwell AM, Shaw DS, Mitchell C, Brooks-Gunn J, McLanahan SS, Forbes EE, Monk CS, Hyde LW. Beyond family-level adversities: Exploring the developmental timing of neighborhood disadvantage effects on the brain. Dev Sci. 2021 Jan;24(1):e12985. PMCID: PMC7669733

Work prior to the UMN MSTP:

Steele VR, Maxwell AM, Ross TJ, Stein EA, Salmeron BJ. Accelerated Intermittent Theta-Burst Stimulation as a Treatment for Cocaine Use Disorder: A Proof-of-Concept Study. Front Neurosci. 2019 Oct 30;13:1147. PMCID: PMC6831547

Lee MR, Caparelli EC, Leff M, Steele VR, Maxwell AM, McCullough K, Salmeron BJ. Repetitive Transcranial Magnetic Stimulation Delivered With an H-Coil to the Right Insula Reduces Functional Connectivity Between Insula and Medial Prefrontal Cortex. Neuromodulation. 2019 Oct 23. [Epub ahead of print]

Steele VR, Maxwell AM, Ross TJ, Moussawi K, Abulseoud OO, Stein EA, Salmeron BJ. Report of transient events in a cocaine-dependent volunteer who received iTBS. Brain Stimul. 2018 May - Jun;11(3):631-633.

Waller R, Dotterer HL, Murray L, Maxwell AM, Hyde LW. White-matter tract abnormalities and antisocial behavior: A systematic review of diffusion tensor imaging studies across development. Neuroimage Clin. 2017 Jan 16;14:201-215. Review. PMCID: PMC5280002